Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Chapple, J. P.
Right arrow Articles by Cheetham, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chapple, J. P.
Right arrow Articles by Cheetham, M. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2000, Vol. 9, No. 13 1919-1926
© 2000 Oxford University Press

Mutations in the N-terminus of the X-linked retinitis pigmentosa protein RP2 interfere with the normal targeting of the protein to the plasma membrane

J. Paul Chapple, Alison J. Hardcastle1, Celene Grayson, L.A. Spackman, Keith R. Willison2 and Michael E. Cheetham+

Department of Pathology and 1Department of Molecular Genetics, Institute of Ophthalmology, University College London, 11–43 Bath Street, London EC1V 9EL, UK and 2Institute of Cancer Research, Chester Beatty Laboratories, London, UK

The X-linked retinitis pigmentosa (XLRP) gene, RP2, codes for a novel 350 amino acid protein of unknown function. We have identified putative sites for N-terminal acyl modification by myristoylation and palmitoylation in the RP2 protein. The RP2 protein is expressed ubiquitously in human tissues at relatively low levels (0.01% of total protein) and has a predominantly plasma membrane localization in cultured cells, as would be expected if the protein was subject to dual N-terminal acylation. Furthermore, mutagenesis of residues potentially required for N-terminal acylation prevents targeting of RP2 to the plasma membrane and the N-terminal 15 amino acids of the protein appear to be sufficient for this targeting. Our data suggest that the protein is dually acylated and that the palmitoyl moiety is responsible for targeting of the myristoylated protein from intracellular membranes to the plasma membrane. The effect of two mutations, which have been reported as causes of XLRP, R118H and {Delta}S6, were investigated. The R118H mutation does not affect the normal plasma membrane localization of RP2; in contrast, the {Delta}S6 mutation interferes with the targeting of the protein to the plasma membrane. Therefore, the {Delta}S6 mutation may cause XLRP because it prevents normal amounts of RP2 reaching the correct cellular locale, whereas the R118H mutation is in a region of the protein that is vital for another aspect of RP2 function in the retina.

+ To whom correspondence should be addressed. Tel: +44 20 7608 6944; Fax: +44 20 7608 6862; Email: michael.cheetham@ucl.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
H. Prokisch, M. Hartig, R. Hellinger, T. Meitinger, and T. Rosenberg
A Population-Based Epidemiological and Genetic Study of X-Linked Retinitis Pigmentosa
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4012 - 4018.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Garcia-Hoyos, B. Garcia-Sandoval, D. Cantalapiedra, R. Riveiro, I. Lorda-Sanchez, M. J. Trujillo-Tiebas, M. Rodriguez de Alba, J. M. Millan, M. Baiget, C. Ramos, et al.
Mutational Screening of the RP2 and RPGR Genes in Spanish Families with X-Linked Retinitis Pigmentosa.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3777 - 3782.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. J. Barnes, J. Richards, M. Mancl, S. Hanash, L. Beretta, and P. M. Pitha
Global and Distinct Targets of IRF-5 and IRF-7 during Innate Response to Viral Infection
J. Biol. Chem., October 22, 2004; 279(43): 45194 - 45207.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
S S Dandekar, N D Ebenezer, C Grayson, J P Chapple, C A Egan, G E Holder, S A Jenkins, F W Fitzke, M E Cheetham, A R Webster, et al.
An atypical phenotype of macular and peripapillary retinal atrophy caused by a mutation in the RP2 gene
Br J Ophthalmol, April 1, 2004; 88(4): 528 - 532.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
I Zito, S M Downes, R J Patel, M E Cheetham, N D Ebenezer, S A Jenkins, S S Bhattacharya, A R Webster, G E Holder, A C Bird, et al.
RPGR mutation associated with retinitis pigmentosa, impaired hearing, and sinorespiratory infections
J. Med. Genet., August 1, 2003; 40(8): 609 - 615.
[Full Text]


Home page
J. Biol. Chem.Home page
J. P. Chapple and M. E. Cheetham
The Chaperone Environment at the Cytoplasmic Face of the Endoplasmic Reticulum Can Modulate Rhodopsin Processing and Inclusion Formation
J. Biol. Chem., May 23, 2003; 278(21): 19087 - 19094.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
I. Bader, O. Brandau, H. Achatz, E. Apfelstedt-Sylla, M. Hergersberg, B. Lorenz, B. Wissinger, B. Wittwer, G. Rudolph, A. Meindl, et al.
X-linked Retinitis Pigmentosa: RPGR Mutations in Most Families with Definite X Linkage and Clustering of Mutations in a Short Sequence Stretch of Exon ORF15
Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1458 - 1463.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. Grayson, F. Bartolini, J. P. Chapple, K. R. Willison, A. Bhamidipati, S. A. Lewis, P. J. Luthert, A. J. Hardcastle, N. J. Cowan, and M. E. Cheetham
Localization in the human retina of the X-linked retinitis pigmentosa protein RP2, its homologue cofactor C and the RP2 interacting protein Arl3
Hum. Mol. Genet., November 15, 2002; 11(24): 3065 - 3074.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. S. Saliba, P. M. G. Munro, P. J. Luthert, and M. E. Cheetham
The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation
J. Cell Sci., July 15, 2002; 115(14): 2907 - 2918.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. P. Chapple, A. J. Hardcastle, C. Grayson, K. R. Willison, and M. E. Cheetham
Delineation of the Plasma Membrane Targeting Domain of the X-Linked Retinitis Pigmentosa Protein RP2
Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 2015 - 2020.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Bartolini, A. Bhamidipati, S. Thomas, U. Schwahn, S. A. Lewis, and N. J. Cowan
Functional Overlap between Retinitis Pigmentosa 2 Protein and the Tubulin-specific Chaperone Cofactor C
J. Biol. Chem., April 19, 2002; 277(17): 14629 - 14634.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
C Grayson, J P Chapple, K R Willison, A R Webster, A J Hardcastle, and M E Cheetham
In vitro analysis of aminoglycoside therapy for the Arg120stop nonsense mutation in RP2 patients
J. Med. Genet., January 1, 2002; 39(1): 62 - 67.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
U. Schwahn, N. Paland, S. Techritz, S. Lenzner, and W. Berger
Mutations in the X-linked RP2 gene cause intracellular misrouting and loss of the protein
Hum. Mol. Genet., May 1, 2001; 10(11): 1177 - 1183.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.